Entrada Therapeutics, Inc. (NASDAQ:TRDA) Director Kush Parmar Sells 25,000 Shares
MarketBeat
Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) Director Kush Parmar sold 25,000 shares of the firm's stock in a transaction on Monday, June 30th. The shares were sold at an average price of $6.81, for a total value of $170,250.00. Following the completion of the sale, the director owned 1,106,670 shares of the company's stock, valued at approximately $7,536,422.70. This trade represents a 2.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
NASDAQ:TRDA